Stereotactic Body Radiotherapy in Prostate Cancer: Is Rapidarc a Better Solution than Cyberknife?

Clinical Oncology

Volumn 26, Issue 1, 2014, Pages 4-9

  MacDougall, N D ^a,b   Dean, C ^a,b   Muirhead, R ^c  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cyberknife; Hypofractionation; Prostate; Rapidarc; SBRT

Indexed keywords

ARTICLE; BLADDER; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CYBERKNIFE; DOSIMETRY; FEMUR HEAD; HUMAN; LINEAR ACCELERATOR; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SIZE; RADIATION DOSE DISTRIBUTION; RADIOSURGERY EQUIPMENT; RAPIDARC; RECTUM; SMALL INTESTINE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; URETHRA;

CYBERKNIFE; HYPOFRACTIONATION; PROSTATE; RAPIDARC; SBRT;

ADENOCARCINOMA; DISEASE-FREE SURVIVAL; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84890806550     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.08.008     Document Type: Article

References (34)

1. Boyyounouski M.K., Price R.A., Harris E.E.R., et al. Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology emerging technology committee. Int J Radiat Oncol Biol Phys 2010, 76:1297-1304.
2. Martin A., Gaya A. Stereotactic body radiotherapy: a review. Clin Oncol 2010, 22:157-172.
3. Peeters S.T.H., Heemsbergen W.D., Koper P.C.M., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multi-center randomized phase III trial comparing 68Gy of radiotherapy with 78Gy. JClin Oncol 2006, 24:1990-1996.
4. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phaseIII randomised trial. Int J Radiat Oncol Biol Phys 2002, 53:1097-1105.
5. Proust-Lima C., Taylor J.M.G., Secher S., et al. Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics. Int J Radiat Oncol Biol Phys 2010, 79:195-201.
6. Williams S.G., Taylor J.M.G., Liu N., et al. Use of individual fraction size data from 3756 patients to directly determine the α/β ratio of prostate cancer. Int J Radiat Oncol Biol Phys 2007, 68:24-33.
7. Madsen B.L., His R.A., Pham H.T., Fowler J.F., Esagui L., Corman J. Stereotactic hypofractionated accurate radiotherapy of the prostate (sharp). 33.5Gy in five fractions for localised disease: first clinical trial results. Int J Radiat Oncol Biol Phys 2007, 67:1099-1105.
8. Tang C.I., Loblaw D.A., Cheung P., et al. Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3. Clin Oncol 2008, 20:729-737.
9. Friedland J.L., Freeman D.E., Masterson-McGary M.E., Spellberg D.M. Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer. Technol Cancer Res Treat 2009, 8:387-392.
10. Bolzicco G., Favretto M.S., Scremin E., Tambone C., Tasca A., Guglielmi R. Image-guided stereotactic body radiation therapy for clinically localized prostate cancer: preliminary clinical results. Technol Cancer Res Treat 2010, 9:473-477.
11. Katz A.J., Santoro M., Ashley R., Diblasio F., Witten M. Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 2010, 10:1.
12. King C.R., Brooks J.E., Gill H., Presti J.C. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 2012, 82:877-882.
13. Jabbari S., Weinberg V.K., Kaprealian T., et al. Stereotactic bodyradiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity and PSA response. Int J Radiat Oncol Biol Phys 2012, 82:228-234.
14. http://www.clinicaltrials.gov/ct2/show/NCT01584258?term=PACE%26rank=12.
15. Palma D., Vollans E., James K., et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:996-1001.
16. International Commission on Radiation Units and Measurements ICRU Report 62. Prescribing, recording and reporting photon beam therapy 1999, ICRU, Bethesda, MD, Supplement to ICRU Report 50.
17. Wilder R.B., Chittenden L., Mesa A.V., et al. Aprospective study of intrafraction prostate motion in the prone vs supine position. Int J Radiat Oncol Biol Phys 2010, 77:165-170.
18. Mutanga T., de Boer H.C.J., Rajan V., Dirkx M.L.P., Incrocci L., Heijmen B.J.M. Day-to-day reproducibility of prostate intrafraction motion assessed by multiple kV and MV imaging of implanted markers during treatment. Int J Radiat Oncol Biol Phys 2012, 83:400-407.
19. Rosewall T., Chung P., Bayley A., et al. Arandomized comparison of interfraction and intrafraction prostate motion with and without abdominal compression. Radiother Oncol 2008, 88:88-94.
20. Aubry J.-F., Beaulieu L., Girouard L.-M., et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys 2004, 60:30-39.
21. Reggiori G., Mancosu P., Tozzi A., et al. Cone beam CT pre- and post-daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer. JApp Clin Med Phys 2011, 12:141-152.
22. Kotte A.N.T.J., Hofman P., Lagendijk J.J.W., van Vulpen M., van der Heide U.A. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Int J Radiati Oncol Biol Phys 2007, 69:419-425.
23. van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol 2004, 14:52-64.
24. Livsey J.E., Wylie J.P., Swindell R., Khoo V.S., Cowan R.A., Logue J.P. Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity?. Int J Radiat Oncol Biol Phys 2004, 60:1076-1081.
25. Chao K.K., Goldstein N.S., Yan D., et al. Clinicopathologic analysis of extracapsular extension in prostate cancer: should the clinical target volume be expanded posteriolaterally to account for microscopic extension?. Int J Radiat Oncol Biol Phys 2006, 65:999-1007.
26. Davis B.J., Pisansky T.M., Wilson T.M., et al. The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy. Cancer 1999, 85:2630-2637.
27. van der Wielen G.J., Mutanga T.F., Incrocci L., et al. Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers. Int J Radiat Oncol Biol Phys 2008, 72:1604-1611.
28. Deurloo K.E.I., Steenbadders R.J.H.M., Zijp L.J., et al. Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy. Int J Radiat Oncol Biol Phys 2005, 61:228-238.
29. Nichol A.M., Brock K.K., Lockwood G.A., et al. Amagnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys 2007, 67:48-56.
30. Stroom J.C., Heijmen B.J.M. Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 report. Radiother Oncol 2002, 64:65-73.
31. http://www.clinicaltrials.gov/ct2/NCT01764646?term=prostate%2Bhypofractionation&rank=9.
32. Kupelian P., Willoughby T., Mahadevan A., et al. Multi-institutional clinical experience with the calypso system in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:1088-1098.
33. Zwahlen D.R., Lang S., Hrbacek J., et al. The use of photon beams of a flattening filter-free linear accelerator for hypofractionated volumetric modulated arc therapy in localised prostate cancer. Int J Radiat Oncol Biol Phys 2012, 83:1655-1660.
34. Lang S., Shrestha B., Graydon S., et al. Clinical application of flattening filter free beams for extracranial stereotactic radiotherapy. Radiother Oncol 2013, 106:255-259.